Sprifermin (rhFGF18) versus vehicle induces a biphasic process of extracellular matrix remodeling in human knee OA articular cartilage ex vivo

Sprifermin, recombinant human fibroblast growth factor 18 (rhFGF18), induces cartilage regeneration in knees of patients with osteoarthritis (OA). We hypothesized that a temporal multiphasic process of extracellular matrix (ECM) degradation and formation underlie this effect. We aimed to characteriz...

Descripción completa

Detalles Bibliográficos
Autores principales: Reker, D., Siebuhr, A. S., Thudium, C. S., Gantzel, T., Ladel, C., Michaelis, M., Aspberg, A., Berchtold, M. W., Karsdal, M. A., Gigout, A., Bay-Jensen, A. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138815/
https://www.ncbi.nlm.nih.gov/pubmed/32265494
http://dx.doi.org/10.1038/s41598-020-63216-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138815/
https://www.ncbi.nlm.nih.gov/pubmed/32265494
http://dx.doi.org/10.1038/s41598-020-63216-z

Ejemplares similares